DrugCite
Search

METHYLPREDNISOLONE ACETATE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Methylprednisolone Acetate Adverse Events Reported to the FDA Over Time

How are Methylprednisolone Acetate adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Methylprednisolone Acetate, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Methylprednisolone Acetate is flagged as the suspect drug causing the adverse event.

Most Common Methylprednisolone Acetate Adverse Events Reported to the FDA

What are the most common Methylprednisolone Acetate adverse events reported to the FDA?

Pyrexia
338 (1.09%)
Cytomegalovirus Infection
298 (.96%)
Drug Ineffective
288 (.93%)
Sepsis
267 (.86%)
Headache
243 (.78%)
Pneumonia
236 (.76%)
Respiratory Failure
215 (.69%)
Dyspnoea
207 (.67%)
Neutropenia
185 (.6%)
Multi-organ Failure
183 (.59%)
Nausea
182 (.59%)
Show More Show More
Anaemia
179 (.58%)
Diarrhoea
176 (.57%)
Condition Aggravated
167 (.54%)
Renal Failure
159 (.51%)
Vomiting
151 (.49%)
Pain
147 (.47%)
Hypertension
144 (.46%)
Thrombocytopenia
144 (.46%)
Asthenia
133 (.43%)
Transplant Rejection
131 (.42%)
Renal Impairment
129 (.42%)
Aspergillosis
127 (.41%)
Hypotension
126 (.41%)
Arthralgia
124 (.4%)
Tendon Rupture
122 (.39%)
Osteonecrosis
121 (.39%)
Diabetes Mellitus
117 (.38%)
Abdominal Pain
115 (.37%)
Septic Shock
112 (.36%)
Back Pain
111 (.36%)
Malaise
111 (.36%)
Depression
110 (.35%)
Infection
110 (.35%)
Fatigue
109 (.35%)
Pain In Extremity
106 (.34%)
Pleural Effusion
104 (.33%)
Haemoglobin Decreased
103 (.33%)
Blood Pressure Increased
100 (.32%)
Dizziness
100 (.32%)
Rash
99 (.32%)
Erythema
96 (.31%)
Tendonitis
96 (.31%)
Blood Creatinine Increased
94 (.3%)
Convulsion
94 (.3%)
Rotator Cuff Syndrome
94 (.3%)
Tachycardia
94 (.3%)
Anxiety
93 (.3%)
Haemodialysis
91 (.29%)
Kidney Transplant Rejection
91 (.29%)
Interstitial Lung Disease
89 (.29%)
Cardiac Arrest
88 (.28%)
Pneumocystis Jiroveci Pneumonia
85 (.27%)
Acute Respiratory Distress Syndrome
82 (.26%)
Gastrointestinal Haemorrhage
82 (.26%)
General Physical Health Deteriorati...
82 (.26%)
Insomnia
82 (.26%)
Urinary Tract Infection
82 (.26%)
Leukopenia
81 (.26%)
Peritonitis
81 (.26%)
Pruritus
81 (.26%)
Weight Increased
79 (.25%)
Death
78 (.25%)
Weight Decreased
78 (.25%)
Hyperglycaemia
77 (.25%)
Pancytopenia
77 (.25%)
Respiratory Distress
77 (.25%)
Staphylococcal Infection
77 (.25%)
Atrial Fibrillation
76 (.24%)
Drug Interaction
75 (.24%)
Hypoaesthesia
75 (.24%)
Urticaria
75 (.24%)
Paraesthesia
74 (.24%)
Graft Versus Host Disease
73 (.23%)
Renal Failure Acute
73 (.23%)
Hypersensitivity
72 (.23%)
Oedema Peripheral
71 (.23%)
Platelet Count Decreased
71 (.23%)
Feeling Abnormal
70 (.23%)
Blood Glucose Increased
69 (.22%)
Complications Of Transplanted Kidne...
69 (.22%)
Confusional State
69 (.22%)
Incorrect Route Of Drug Administrat...
69 (.22%)
Ascites
67 (.22%)
Bone Marrow Failure
67 (.22%)
Hepatic Function Abnormal
66 (.21%)
Drug Exposure During Pregnancy
65 (.21%)
Gait Disturbance
64 (.21%)
Hyperhidrosis
64 (.21%)
Histiocytosis Haematophagic
63 (.2%)
Muscular Weakness
63 (.2%)
Chest Pain
61 (.2%)
Hepatic Failure
61 (.2%)
Loss Of Consciousness
61 (.2%)
Abdominal Distension
60 (.19%)
Heart Rate Increased
60 (.19%)
Fall
59 (.19%)
Chills
58 (.19%)
Febrile Neutropenia
58 (.19%)
White Blood Cell Count Increased
58 (.19%)
Aspartate Aminotransferase Increase...
57 (.18%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Methylprednisolone Acetate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Methylprednisolone Acetate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Methylprednisolone Acetate

What are the most common Methylprednisolone Acetate adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Methylprednisolone Acetate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Methylprednisolone Acetate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Methylprednisolone Acetate According to Those Reporting Adverse Events

Why are people taking Methylprednisolone Acetate, according to those reporting adverse events to the FDA?

Rheumatoid Arthritis
1053
Premedication
898
Drug Use For Unknown Indication
689
Product Used For Unknown Indication
577
Renal Transplant
459
Immunosuppression
351
Show More Show More
Multiple Sclerosis
244
Prophylaxis Against Graft Versus Ho...
236
Liver Transplant
218
Prophylaxis Against Transplant Reje...
201
Graft Versus Host Disease
182
Asthma
176
Prophylaxis
168
Acute Lymphocytic Leukaemia
158
Systemic Lupus Erythematosus
130
Immunosuppressant Drug Therapy
104
Arthritis
98
Pain
96
Lupus Nephritis
90
Back Pain
89
Inflammation
84
Interstitial Lung Disease
79
Non-hodgkins Lymphoma
78
Multiple Sclerosis Relapse
77
Chronic Obstructive Pulmonary Disea...
75
Crohns Disease
74
Nephrotic Syndrome
72
Ill-defined Disorder
71
Lung Transplant
68
Arthralgia
65
Juvenile Arthritis
61
Chronic Lymphocytic Leukaemia
58
Transplant Rejection
58
Breast Cancer Metastatic
58
Acute Graft Versus Host Disease
57
Aplastic Anaemia
57
Dermatomyositis
56
Colitis Ulcerative
52
Hypersensitivity
49
Wegeners Granulomatosis
48
Pneumonia
47
Bronchitis
46
Diffuse Large B-cell Lymphoma
44
B-cell Lymphoma
44
Lymphoma
44
Severe Acute Respiratory Syndrome
43
Vasculitis
42
Multiple Myeloma
41
Psoriatic Arthropathy
41
Kidney Transplant Rejection
40
Sinusitis
39

Drug Labels

LabelLabelerEffective
Depo-medrolPharmacia and Upjohn Company30-MAR-10
Depo-medrolPharmacia and Upjohn Company19-APR-10
Depo-medrolPhysicians Total Care, Inc.20-APR-10
Depo-medrolPharmacia and Upjohn Company20-APR-10
Depo-medrolPharmacia and Upjohn Company20-APR-10
MethylprednisoloneTeva Parenteral Medicines, Inc15-SEP-10
Methylprednisolone AcetateRebel Distributors Corp17-JAN-11
Depo-medrolRebel Distributors Corp28-JUN-11
Methylprednisolone AcetateSandoz Inc20-OCT-11
Depo-medrolDispensing Solutions, Inc.01-FEB-12
Depo-medrolCardinal Health06-AUG-12
Methylprednisolone AcetateTeva Parenteral Medicines, Inc.11-AUG-12
Methylprednisolone AcetatePhysicians Total Care, Inc.29-AUG-12
Methylprednisolone AcetateSandoz Inc18-MAR-13
Depo-medrolREMEDYREPACK INC. 10-APR-13
Depo-medrolPharmacia and Upjohn Company24-APR-13

Methylprednisolone Acetate Case Reports

What Methylprednisolone Acetate safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Methylprednisolone Acetate. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Methylprednisolone Acetate.